Analysts’ consensus projections for Elevance Health's forthcoming report indicate earnings of $9.19 per share on revenue of ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $484.4, a high estimate of $522.00, and a low estimate of $434.00. A negative shift in sentiment ...

The Cigna Group's fundamentals are solid, but the stock is fairly valued versus peers, not a bargain. Click here to find out ...

Ten analysts recently shared bullish-to-bearish takes on Elevance Health over the last three months, leaning heavily bullish.

A proposed payment rule unveiled Monday by CMS aims to reduce unnecessary spending and boost quality measures, as well as ...

CMS proposes sweeping payment changes to cut waste, refocus on chronic care, and modernize reimbursement across Medicare services and providers.

Cyclacel stock spikes on high volume amid recent cancer study and deal amendment with FITTERS, despite no new official ...

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The ...

UnitedHealth Group is juggling regulatory headaches and financial setbacks while trying to pivot back to stability and growth ...